BACKGROUND: β-thalassemic syndromes are inherited red cell disorders characterized by severe ineffective erythropoiesis and increased levels of reactive oxygen species whose contribution to β-thalassemic anemia is only partially understood. DESIGN AND METHODS: We studied erythroid precursors from normal and β-thalassemic peripheral CD34(+) cells in two-phase liquid culture by proteomic, reverse transcriptase polymerase chain reaction and immunoblot analyses. We measured intracellular reactive oxygen species, heme levels and the activity of δ-aminolevulinate-synthase-2. We exposed normal cells and K562 cells with silenced peroxiredoxin-2 to H(2)O(2) and generated a recombinant peroxiredoxin-2 for kinetic measurements in the presence of H(2)O(2) or hemin. RESULTS: In β-thalassemia the increased production of reactive oxygen species was associated with down-regulation of heme oxygenase-1 and biliverdin reductase and up-regulation of peroxiredoxin-2. In agreement with these observations in β-thalassemic cells we found decreased heme levels related to significantly reduced activity of the first enzyme of the heme pathway, δ-aminolevulinate synthase-2 without differences in its expression. We demonstrated that the activity of recombinant δ-aminolevulinate synthase-2 is inhibited by both reactive oxygen species and hemin as a protective mechanism in β-thalassemic cells. We then addressed the question of the protective role of peroxiredoxin-2 in erythropoiesis by exposing normal cells to oxidative stress and silencing peroxiredoxin-2 in human erythroleukemia K562 cells. We found that peroxiredoxin-2 expression is up-regulated in response to oxidative stress and required for K562 cells to survive oxidative stress. We then showed that peroxiredoxin-2 binds heme in erythroid precursors with high affinity, suggesting a possible multifunctional cytoprotective role of peroxiredoxin-2 in β-thalassemia. CONCLUSIONS: In β-thalassemic erythroid cells the reduction of δ-aminolevulinate synthase-2 activity and the increased expression of peroxiredoxin-2 might represent two novel stress-response protective systems.
BACKGROUND: β-thalassemic syndromes are inherited red cell disorders characterized by severe ineffective erythropoiesis and increased levels of reactive oxygen species whose contribution to β-thalassemic anemia is only partially understood. DESIGN AND METHODS: We studied erythroid precursors from normal and β-thalassemic peripheral CD34(+) cells in two-phase liquid culture by proteomic, reverse transcriptase polymerase chain reaction and immunoblot analyses. We measured intracellular reactive oxygen species, heme levels and the activity of δ-aminolevulinate-synthase-2. We exposed normal cells and K562 cells with silenced peroxiredoxin-2 to H(2)O(2) and generated a recombinant peroxiredoxin-2 for kinetic measurements in the presence of H(2)O(2) or hemin. RESULTS: In β-thalassemia the increased production of reactive oxygen species was associated with down-regulation of heme oxygenase-1 and biliverdin reductase and up-regulation of peroxiredoxin-2. In agreement with these observations in β-thalassemic cells we found decreased heme levels related to significantly reduced activity of the first enzyme of the heme pathway, δ-aminolevulinate synthase-2 without differences in its expression. We demonstrated that the activity of recombinant δ-aminolevulinate synthase-2 is inhibited by both reactive oxygen species and hemin as a protective mechanism in β-thalassemic cells. We then addressed the question of the protective role of peroxiredoxin-2 in erythropoiesis by exposing normal cells to oxidative stress and silencing peroxiredoxin-2 in human erythroleukemia K562 cells. We found that peroxiredoxin-2 expression is up-regulated in response to oxidative stress and required for K562 cells to survive oxidative stress. We then showed that peroxiredoxin-2 binds heme in erythroid precursors with high affinity, suggesting a possible multifunctional cytoprotective role of peroxiredoxin-2 in β-thalassemia. CONCLUSIONS: In β-thalassemic erythroid cells the reduction of δ-aminolevulinate synthase-2 activity and the increased expression of peroxiredoxin-2 might represent two novel stress-response protective systems.
Authors: Matthias Schranzhofer; Manfred Schifrer; Javier Antonio Cabrera; Stephan Kopp; Peter Chiba; Hartmut Beug; Ernst W Müllner Journal: Blood Date: 2006-01-19 Impact factor: 22.113
Authors: Xiang Yu; Yi Kong; Louis C Dore; Osheiza Abdulmalik; Anne M Katein; Suiping Zhou; John K Choi; David Gell; Joel P Mackay; Andrew J Gow; Mitchell J Weiss Journal: J Clin Invest Date: 2007-07 Impact factor: 14.808
Authors: Ethan G Thompson; Smitha Shankar; Hannah P Gideon; Jackie Braun; Joe Valvo; Jason A Skinner; Alan Aderem; JoAnne L Flynn; Philana Ling Lin; Daniel E Zak Journal: J Infect Dis Date: 2018-03-28 Impact factor: 5.226
Authors: Claire F Dickson; Anne M Rich; William M H D'Avigdor; Daniel A T Collins; Jason A Lowry; Todd L Mollan; Eugene Khandros; John S Olson; Mitchell J Weiss; Joel P Mackay; Peter A Lay; David A Gell Journal: J Biol Chem Date: 2013-05-21 Impact factor: 5.157
Authors: Marina Bayeva; Arineh Khechaduri; Rongxue Wu; Michael A Burke; J Andrew Wasserstrom; Neha Singh; Marc Liesa; Orian S Shirihai; Nathaniel B Langer; Barry H Paw; Hossein Ardehali Journal: Circ Res Date: 2013-05-29 Impact factor: 17.367
Authors: Lucia De Franceschi; Robert S Franco; Mariarita Bertoldi; Carlo Brugnara; Alessandro Matté; Angela Siciliano; Adam J Wieschhaus; Athar H Chishti; Clinton H Joiner Journal: FASEB J Date: 2012-10-19 Impact factor: 5.191